18. Albumin excretion rate ‐ Studies undertaking multivariable regression analyses to determine the effect of albumin excretion rate on progression to PDR.
Study | Study type | Time years | N at baseline | Adjustment factors | Effect estimate | P value | Comments | ||
Type | Value | 95% CI | |||||||
Type 1 diabetes | |||||||||
Roy 2006 | Prospective cohort | 6 | 725 | HbA1c, age, hypertension | OR | 2.40 | 1.09 to 5.29 | 0.009 | Microproteinuria |
Porta 2001 | Prospective cohort | 7 | 2013 | HbA1c, DM duration, DR severity at baseline, age of DM diagnosis < 12 years, DBP, waist‐to‐height ratio | Regression estimate | 1.33 | 1.12 to 1.58 | 0.001 | With increasing level |
Type 2 diabetes | |||||||||
Kim 1998 | Prospective cohort | 5 | 56 | HbA1c, DM duration, age, change in BMI | RR | 1.34 | 0.31 to 5.82 | With increasing level |
BMI: body mass index; CI: confidence interval; DBP: diastolic blood pressure; DM: diabetes mellitus; DR: diabetic retinopathy; HbA1c: glycated haemoglobin/haemoglobin A1c; HR: hazard ratio; NPDR: non‐proliferative diabetic retinopathy; OR: odds ratio; PDR: proliferative diabetic retinopathy; RR: risk ratio; SBP: systolic blood pressure; vs: versus